Member Info for rhubarbmk2

You are correct that it was ramped.

In my opinion, you are not correct that it was overpriced.

Every fundamental within this Company is suggestive of a 50M MCap, as we stand today.

Unfortunately, the AIM doesn't breed stability on caps that are still in "theory" or "promise" mode.

We're off there now, and should by rights be joining the ranks of the "proven" bio outfits.

The price crash yesterday was undertaken by a number of people who are not investors, and others who subsequently panicked.

Do not let that fool anyone into not realising that the fundamentals of VAL are now much changed, as they stood at 6.59am yesterday.

I'm with you there Iceman.

On a funny note, what are the chances of having two TheoremRXs? It's not exactly an obvious Company name choice is it.

Poor Theo, of TheoremRX Number 1. I bet he's been inundated with e-mails from Ells, Nomong, and Terrier.

Poor fella probably threw himself off a bridge.

And yet at SAR, the CEO reads Sierra's RNS's, to find out when they'll "un-park" his lead asset.

Sorry; I don't generally do sl*gging of others if I can help it, but I'm making an exception for you.

Know where I'd rather be.

https://www.brrmedia.co.uk/broadcasts/618169a029c8b82a5a01e169/valirx---signs-letter-of-intent-to-sub-license-val201/

OB - finally.

We were waiting for a measured and balanced "mature" perspective from you, and here you are.

What I do know, is that those who want to sleep on it, will do, and then they'll hopefully come to a conclusion as I have.

There is nothing wrong with the deal. Suzy has ventured into US Private Capital, so we are killing two birds with one stone here, because she's setting herself up for the future direction. She has a very respectably deal from someone else's venture and a very less-than-ideal and incomplete dataset. This ain't gonna happen again.

If we get 3 indications, we have a chance x 3 of hitting 150% of our current MCap. I do not know the royalty level, until Suzy steps in, but I'll plumb for 7% of sales.

If 201 works as well as it should, at higher and more repetitive doses, then I'll let folk have a stab at working that out, as a yearly payment. Drugs that work well have annual sales freely published.

21MCap.

Sleep on it, and have a think on that, is my only advice.

Good Evening.

And so is Nick; just to clarify.

I know this will disappoint, but yes; I am buying again.

50MCap anywhere else for our stage. It will come.

Then we'll move with 2 preclinical assets and nudge three figures.

I'm just putting this here, so I can cut and paste it when required.

"Fluff" = failure to accomplish something successfully or well.

It's your investment strategy Ells!

Congratulations Elliot. We have many varied personality types in this board, but we were lacking a "classic" Cluster B Narcissist.

I'm glad you've filled that void.

Simply put, Porky; misery loves Company.

Unfortunately, many here have neither the brain or the acumen to make money on biotech off their own back, without trying to manipulate others.

It'd be nice for them to experience getting out of bed with a spring in their step.

Fair enough. As you say, two sides of the same coin.

As one side is fairly sinister though, I suppose I'm just a bit disappointed that your fact checker seems a little focused elsewhere.

Well we are up over +70% in the past month, so let's not quibble over insignificant technicals, Jenny.

Mines 50K more shares.

Thanks Betty!

Agreed. Just added some tranches based on that chart.

Thanks for posting.

It's a nice position to be in, isn't it, Novice.

Investing in a Company, run by a series' of the straightest bats, with a number of guaranteed inflection points over the next six months.

Reckon so. Who'd risk out, for the sake of a few quid.

That's a swing high, natch. Congrats if you bought in.

That's where the TA gets shot on here. If we were not aware of news, then I wouldn't be surprised to see a series of swing lows, after some initial anticipatory runs.

But we are, so the above just ain't gonna happen to a material degree, IMO.

I don't think it's inferior to trade, without any interest or knowledge of the Company.

It's just that I find those who do, generally have posts that are just mind-numbingly boring.